Coeptis Therapeutics Holdings Inc
COEPW0.018USD
+0.003+20.81%
Cierre 11/07, 16:00（ET）Cotizaciones retrasadas 15 min
0.00Cap. mercado
--P/E TTM
Más Datos de Coeptis Therapeutics Holdings Inc Compañía
Coeptis Therapeutics Holdings, Inc. is a biopharmaceutical company developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Its product portfolio is highlighted by assets licensed from Deverra Therapeutics, including an allogeneic cellular immunotherapy platform and DVX201, a clinical-stage, unmodified natural killer cell therapy technology. It is developing a universal, multi-antigen CAR technology licensed from the University of Pittsburgh (SNAP-CAR), and the GEAR cell therapy and companion diagnostic platforms in collaboration with VyGen-Bio and medical researchers at the Karolinska Institute. Its NexGenAI Affiliates Network platform offers AI-powered marketing software and advanced robotic process automation capabilities. Its Coeptis Technologies division is focused on diversifying and enhancing its growth potential. Its subsidiaries include Coeptis Therapeutics, Inc., Coeptis Pharmaceuticals, Inc., GEAR Therapeutics, Inc. and SNAP Biosciences, Inc.
Información de Coeptis Therapeutics Holdings Inc
Símbolo de cotizaciónCOEPW
Nombre de la empresaCoeptis Therapeutics Holdings Inc
Fecha de salida a bolsaDec 17, 2020
Director ejecutivo- -
Número de empleados- -
Tipo de seguridadCompany Warrant
Fin del año fiscal- -
Dirección105 Bradford Road, Suite 420
CiudadWEXFORD
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal15090
Teléfono17249346467
Sitio Webhttps://coeptistx.com/
Símbolo de cotizaciónCOEPW
Fecha de salida a bolsaDec 17, 2020
Director ejecutivo- -
Ejecutivos de Coeptis Therapeutics Holdings Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. David Mehalick
Mr. David Mehalick
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Ms. Christine Sheehy
Ms. Christine Sheehy
Vice President - Compliance, Secretary
Vice President - Compliance, Secretary
--
--
Mr. Christopher Calise
Mr. Christopher Calise
Independent Director
Independent Director
--
--
Mr. Christopher Cochran
Mr. Christopher Cochran
Independent Director
Independent Director
--
--
Mr. Philippe Deschamps
Mr. Philippe Deschamps
Independent Director
Independent Director
--
--
Dr. Tara Maria Desilva, Ph.D.
Dr. Tara Maria Desilva, Ph.D.
Independent Director
Independent Director
--
--
Mr. Brian Cogley
Mr. Brian Cogley
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Daniel (Dan) Yerace
Mr. Daniel (Dan) Yerace
Vice President - Operations, Director
Vice President - Operations, Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. David Mehalick
Mr. David Mehalick
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Ms. Christine Sheehy
Ms. Christine Sheehy
Vice President - Compliance, Secretary
Vice President - Compliance, Secretary
--
--
Mr. Christopher Calise
Mr. Christopher Calise
Independent Director
Independent Director
--
--
Mr. Christopher Cochran
Mr. Christopher Cochran
Independent Director
Independent Director
--
--
Mr. Philippe Deschamps
Mr. Philippe Deschamps
Independent Director
Independent Director
--
--
Dr. Tara Maria Desilva, Ph.D.
Dr. Tara Maria Desilva, Ph.D.
Independent Director
Independent Director
--
--
Desglose de ingresos
Sin datos
Sin datos
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: jue., 2 de oct
Actualizado: jue., 2 de oct
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Otro
100.00%
Accionistas
Accionistas
Proporción
Otro
100.00%
Tipos de accionistas
Accionistas
Proporción
Otro
100.00%
Participación institucional
Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
25
918.20K
0.00%
-367.10K
2025Q2
25
830.98K
0.00%
-949.99K
2025Q1
26
830.98K
0.00%
-1.05M
2024Q4
29
1.01M
0.00%
-1.53M
2024Q3
33
1.78M
0.00%
-1.61M
2024Q2
34
2.07M
0.00%
-1.33M
2024Q1
34
2.12M
0.00%
-666.88K
2023Q4
33
1.49M
0.00%
-1.25M
2023Q3
31
1.50M
0.00%
-1.41M
2023Q2
30
2.00M
0.00%
-919.99K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Clear Street LLC
200.00
0%
+200.00
--
Jun 30, 2025
IONIC Capital Management, L.L.C.
--
0%
-93.56K
-100.00%
Dec 31, 2024
TD Securities, Inc.
44.95K
0%
+44.95K
--
Jun 30, 2025
Susquehanna International Group, LLP
54.68K
0%
+54.68K
--
Jun 30, 2025
Meteora Capital LLC
250.00K
0%
-2.23K
-0.88%
Jun 30, 2025
RiverNorth Capital Management LLC
149.90K
0%
-100.00
-0.07%
Jun 30, 2025
Walleye Trading, LLC
130.17K
0%
-1.10K
-0.84%
Jun 30, 2025
Cantor Fitzgerald, L.P
106.46K
0%
--
--
Jun 30, 2025
Skyview Investment Advisors, LLC
55.12K
0%
--
--
Jun 30, 2025
CSS, LLC
38.85K
0%
--
--
Jun 30, 2025
Ver más
ETFs relacionados
Nombre
Proporción
Sin datos
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
